Point72 Hong Kong LTD Horizon Therapeutics Public LTD CO Transaction History

Point72 Hong Kong LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $810,356 - $1.19 Million	-10,206 Reduced 47.46%	11,297 $901,000
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $1.85 Million - $2.35 Million	21,372 Added 16314.5%	21,503 $2.26 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $12,911 - $15,708	131 New	131 $14,000
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $1.36 Million - $1.63 Million	-14,785 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $1.28 Million - $1.42 Million	14,785 New	14,785 $1.38 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $1.33 Million - $1.68 Million	-19,888 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $1.09 Million - $1.58 Million	19,758 Added 15198.46%	19,888 $1.55 Million
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $72,782 - $137,321	-2,410 Reduced 94.88%	130 $7,000
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $37,976 - $58,881	1,527 Added 150.74%	2,540 $75,000
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $25,760 - $37,146	1,013 New	1,013 $37,000
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $161 - $195	-7 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $159 - $199	7 New	7 $0

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.